Invention Grant
- Patent Title: Antibodies with modulated glycan profiles
-
Application No.: US17051528Application Date: 2019-04-30
-
Publication No.: US12084686B2Publication Date: 2024-09-10
- Inventor: Christopher Kenyon Crowell , Jian Wu , Neil Kitchen , Alison Jean Gillespie , Simina Crina Petrovan , Michael Charles Brandenstein
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN INC.
- Current Assignee: AMGEN INC.
- Current Assignee Address: US CA Thousand Oaks
- International Application: PCT/US2019/029850 2019.04.30
- International Announcement: WO2019/213043A 2019.11.07
- Date entered country: 2020-10-29
- Main IPC: C12P21/00
- IPC: C12P21/00 ; C07K16/00 ; C07K16/28 ; C12N1/38 ; C12N5/071 ; C12N5/16
Abstract:
This invention relates to recombinantly-expressed denosumab molecules and methods for modulating glycan profiles of denosumab molecules.
Public/Granted literature
- US20210062156A1 ANTIBODIES WITH MODULATED GLYCAN PROFILES Public/Granted day:2021-03-04
Information query
